Furosemide and spironolactone doses and hyponatremia in patients with heart failure | BMC Pharmacology and Toxicology | Full Text

Furosemide and spironolactone doses and hyponatremia in patients with heart failure | BMC Pharmacology and Toxicology | Full Text

Furosemide and spironolactone doses and hyponatremia in patients with heart failure

Hyponatremia, a marker of disease severity and prognosis, has been associated with various clinical factors and drug use, especially diuretics.

Authors:Ivan Velat, Željko Bušić, Marina Jurić Paić and Viktor Čulić

Citation:BMC Pharmacology and Toxicology 2020 21:57

Content type:Research article

 

Published on: 3 August 2020

• ViewFull Text
 
• ViewPDF